← SynDRA
AMBENONIUM
SynDRA canonical compound SYN0016288 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · OTC |
|---|
| Primary target(s) | ACHE |
|---|
| Mechanism of action | Cholinesterase inhibitor |
|---|
| Indication | myasthenia gravis |
|---|
| Disease area | neurology/psychiatry |
|---|
All known targets
Mechanisms of action (all sources)
- Cholinesterase inhibitor
- ACHE INHIBITOR
- Acetylcholinesterase inhibitor
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- CHRM2
- OPRK1
- SLC6A4
- SLC6A2
- ADRA2C
- CHRM3
- CHRM1
- KCNH2
- OPRM1
- MC3R
- MAOA
- HTR3A
- NPY1R
- HTR2C
- HTR2B
- HTR2A
- HTR1A
- MLNR
- ADORA1
- NR1I2
- NR3C1
- HRH2
- OPRD1
- PDE3A
- PDE4D
- PGR
- PTGS2
- SLC6A3
- HRH3
- GHSR
- HRH1
- CHRNA4
- ADORA3
- ADRA2A
- ADRA2B
- ADRB1
- AGTR1
- AVPR1A
- AVPR2
- BDKRB2
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Drug classes
- Cholinesterase Inhibitors
- Cholinergic Agents
- Enzyme Inhibitors
- Neurotransmitter Agents
- Parasympathomimetics
- Peripheral Nervous System Agents
- Cholinesterase Inhibitor
ATC classes
- N07A · PARASYMPATHOMIMETICS
Cross-references
Synonyms
- MYTELASE
- ambenonium chloride
- ambestigmin chloride
- mytelase chloride
- mytelase
- Ambenonium cation
- Ambenonium ion
- Ambenonum
- Ambenonium Base
- Ambenonium kation
- Mytelase (TN)
- Ambenonium [USAN]
- L16PUN799N
- AMBENONIUM [VANDF]
- AMBENONIUM [WHO-DD]
- CHEBI:2627
- OXALYLBIS(IMINOETHYLENE))BIS((O-CHLOROBENZYL)DIETHYLAMMONIUM
- RefChem:556872
- DTXCID6028369
- NCGC00163221-01
- UNII-L16PUN799N
- Tocris-0388
- SCHEMBL284678
- orb1737736
- BDBM50262988
- STL430453
- AKOS037479279
- NCGC00024567-01
- NCGC00024567-02
- NS00069747
- C07773
- BRD-K11292736-300-02-8
- Ambenonium base
- Ambenonium dichloride
- Mytelase
- Оксазил
- Амбенонію хлорид
- Ambenonio
Look up AMBENONIUM in the interactive SynDRA portal →